Globus Medical
GMED
408 hedge funds and large institutions have $5.69B invested in Globus Medical in 2023 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 131 increasing their positions, 163 reducing their positions, and 65 closing their positions.
625% more call options, than puts
Call options by funds: $26.2M | Put options by funds: $3.61M
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
5% more capital invested
Capital invested by funds: $5.43B → $5.69B (+$253M)
0.74% less ownership
Funds ownership: 93.23% → 92.5% (-0.74%)
5% less funds holding
Funds holding: 430 → 408 (-22)
20% less repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 163
20% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 65
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$80.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$46.2M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$40.8M |
| 4 |
SC
Sculptor Capital
New York
|
+$35.4M |
| 5 |
BAM
Burgundy Asset Management
Toronto,
Ontario, Canada
|
+$32.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Nuance Investments
Kansas City,
Missouri
|
-$180M |
| 2 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
-$111M |
| 3 |
Two Sigma Investments
New York
|
-$34.1M |
| 4 |
D.E. Shaw & Co
New York
|
-$27.1M |
| 5 |
Two Sigma Advisers
New York
|
-$26.9M |
GMED Hedge Fund Activity: Q4 2023 in Review
408 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q4 2023, worth a combined $5.69B — up 4.7% from $5.43B a quarter earlier.
Sellers outnumbered buyers: 65 funds closed out of GMED and 52 opened new positions — a net loss of 13 holders — while 163 trimmed existing stakes and 131 added.
The largest buyer was Millennium Management, adding an estimated $80.5M. The largest seller was Nuance Investments, exiting entirely with an estimated $180M sold.
- 408 institutional investors held Globus Medical (GMED) as of Q4 2023, down from 430 in Q3 2023.
- Funds reported $5.69B of Globus Medical stock for Q4 2023, up 4.7% quarter-over-quarter.
- 52 funds opened new Globus Medical positions in Q4 2023 and 65 closed out, a net change of -13 holders.
- The largest Globus Medical buyer in Q4 2023 was Millennium Management, an estimated $80.5M added.
- The largest Globus Medical seller in Q4 2023 was Nuance Investments, an estimated $180M sold.
Based on aggregated 13F filings for Q4 2023.